Trial intelligence / Profile preview

Add-Vacc: Male Single Dose HPV Vaccination in Tanzania

NCT04953130Phase 4Recruiting

Sponsor
London School of Hygiene & Tropical Medicine
Start
Aug 2022
Primary completion
Dec 2026
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of qHPV vaccine in human papillomavirus infection, sponsored by London School of Hygiene & Tropical Medicine. Started Aug 2022; status: recruiting.

02

Drugs

qHPV vaccine
03

Conditions

human papillomavirus infection

Beyond the preview

Go deeper on NCT04953130.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04953130.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call